Cargando…
Skipping a pillar does not make for strong foundations: Pharmacokinetic‐pharmacodynamic reasoning behind the shape of dose–response relationships in oncology
Dose–response analysis is often applied to the quantification of drug‐effect especially for slowly responding disease end points where a comparison is made across dose levels after a particular period of treatment. It has long been recognized that exposure – response is more appropriate than dose–re...
Autores principales: | Yates, James W. T., Mistry, Hitesh B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681527/ https://www.ncbi.nlm.nih.gov/pubmed/37771203 http://dx.doi.org/10.1002/psp4.13020 |
Ejemplares similares
-
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
por: Bruin, Maaike A. C., et al.
Publicado: (2022) -
Using Network Biology to Bridge Pharmacokinetics and Pharmacodynamics in Oncology
por: Kirouac, D C, et al.
Publicado: (2013) -
Teleoncology: The Youngest Pillar of Oncology
por: Pareek, Puneet, et al.
Publicado: (2020) -
Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology
por: Ait-Oudhia, Sihem, et al.
Publicado: (2014) -
Colistin pharmacokinetics/pharmacodynamics and acute kidney injury: A difficult but reasonable marriage
por: Honore, Patrick M., et al.
Publicado: (2014)